A Utah startup has quickly made big strides in drug research. In just three years, Recursion Pharmaceuticals has found a way to put a time-consuming process on a fast track.
There is a sense of pride, optimism and excitement as Recursion CEO and co-founder Chris Gibson shows us around the ever-expanding company with its state-of-the-art labs.
